Last reviewed · How we verify

NCT05995730

Effect of Lavender Inhalation on Dysmenorrhea

Status unknown NA Last updated 16 August 2023
What this trial tests

NA trial testing Lavender oil inhalation in Dysmenorrhea in 51 participants. Status unknown.

Timeline
1 January 2023
Primary endpoint
15 December 2023
15 May 2024

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposesupportive care
Enrollment51
Start date1 January 2023
Primary completion15 December 2023
Estimated completion15 May 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 18 to 30, female only, with Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned to determine the effect of lavender inhalation on primary dysmenorrhea and its symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lavender oil inhalation

Trials testing the same drug.

Other recruiting trials for Dysmenorrhea

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05995730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing